BioArctic
Biopharmaceutical firm developing antibody therapies for neurodegenerative diseases.
BIOA | ST
Overview
Corporate Details
- ISIN(s):
- SE0010323303 (+1 more)
- LEI:
- 549300Y0OI2WVUNHLC33
- Country:
- Sweden
- Address:
- Warfvinges väg 35, 112 51 Stockholm
- Website:
- https://www.bioarctic.se/en/
Description
BioArctic is a research-intensive biopharmaceutical company focused on developing disease-modifying treatments, biomarkers, and diagnostics for neurodegenerative diseases. The company's core strategy is based on its proprietary antibody technology, which develops unique treatments that target the misfolded and aggregated proteins considered to be the underlying cause of disorders such as Alzheimer's and Parkinson's disease. Through strategic partnerships with global pharmaceutical companies, BioArctic advances its innovative therapies from research through clinical development and commercialization, aiming to address significant unmet medical needs in neurology.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2018-04-25 11:00 |
Inclusion completed of patients with complete spinal cord injury in the first p…
|
English | 189.2 KB | ||
| 2018-04-24 10:00 | Swedish | 2.8 MB | |||
| 2018-04-24 10:00 | English | 2.8 MB | |||
| 2018-04-13 13:00 |
NOTICE OF ANNUAL GENERAL MEETING IN BIOARCTIC AB (PUBL)
|
English | 175.5 KB | ||
| 2018-04-13 13:00 |
KALLELSE TILL ÅRSSTÄMMA I BIOARCTIC AB (PUBL)
|
Swedish | 115.5 KB | ||
| 2018-04-12 08:01 |
Inbjudan till presentation av BioArctics delårsrapport januari – mars 2018 den …
|
Swedish | 173.3 KB | ||
| 2018-04-12 08:01 |
Invitation to presentation of BioArctic’s Interim Report January – March 2018 o…
|
English | 174.8 KB | ||
| 2018-03-21 13:00 |
BioArctic får myndighetsgodkännande i Norge för klinisk studie med patienter so…
|
Swedish | 183.1 KB | ||
| 2018-03-21 13:00 |
BioArctic receives regulatory approval in Norway for a clinical study in patien…
|
English | 182.4 KB | ||
| 2018-03-19 13:00 |
BioArctic får patentskydd i Japan för en medicinteknisk produkt för behandling …
|
Swedish | 188.0 KB | ||
| 2018-03-19 13:00 |
BioArctic receives patent protection in Japan for a medical device for treatmen…
|
English | 186.4 KB | ||
| 2018-03-09 13:05 | English | 34.5 KB | |||
| 2018-02-21 11:00 |
BioArctic receives regulatory approval in Estonia for a clinical study in patie…
|
English | 182.6 KB | ||
| 2018-02-21 11:00 |
BioArctic får myndighetsgodkännande i Estland för klinisk studie med patienter …
|
Swedish | 181.1 KB | ||
| 2018-02-20 08:01 | Swedish | 506.9 KB |
Automate Your Workflow. Get a real-time feed of all BioArctic filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for BioArctic
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for BioArctic via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-02-13 | Gunilla Osswald | Other | Sell | 40,000 | 8,821,200.00 SEK |
| 2025-02-13 | Gunilla Osswald | Other | Other | 40,000 | 3,344,000.00 SEK |
| 2025-02-13 | Sten Mikael Moge | Other | Sell | 6,000 | 1,323,180.00 SEK |
| 2025-02-13 | Sten Mikael Moge | Other | Other | 6,000 | 501,600.00 SEK |
| 2025-02-13 | Johanna Margareta Fälting | Other | Sell | 1,500 | 330,795.00 SEK |
| 2025-02-13 | Johanna Margareta Fälting | Other | Other | 2,500 | 209,000.00 SEK |
| 2025-02-13 | Johanna Margareta Fälting | Other | Other | 1,500 | 125,400.00 SEK |
| 2025-01-10 | Mikael Smedeby | Other | Buy | 730 | 148,920.00 SEK |
| 2024-12-19 | Oskar Bosson | Other | Sell | 2,000 | 446,000.00 SEK |
| 2024-12-19 | Oskar Bosson | Other | Sell | 871 | 195,626.60 SEK |
Peer Companies
